Harrisburg, NC -- (SBWIRE) -- 10/22/2020 -- The Global Biologics Market Research Report 2020-2030 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report.
Inquire here to avail discount on this report:
https://www.marketinsightsreports.com/reports/0927879758/biologics-global-market-opportunities-and-strategies-to-2021-including-monoclonal-antibodies-therapeutic-proteins-vaccines-covering-amgen-abbvie-johnson-johnson-bristol-meyers-squibb-pfizer-inc-eli-lilly-and-company-f-hoffmann-la-roche-merck-co-glaxosmithkline-sanofi?source=releasewire&Mode=68
Market Segmentation
Top leading Companies of Global Biologics Market are – Amgen, AbbVie, Johnson & Johnson, Bristol-Meyers Squibb, Pfizer Inc., Eli Lilly and Company, F. Hoffmann- La Roche, Merck & Co., GlaxoSmithKline, Sanofi
The global biologics market was worth $221 billion in 2017 and is essentially segmented into monoclonal antibodies, therapeutic proteins and vaccines. Biologics are very large complex molecules manufactured in a living system such as microorganisms, animal cells or plant cells. They are produced using the recombinant DNA technology and are composed of sugars, proteins, nucleic acids or a combination of these substances. In 2017, 12 biologics were approved in the USA, 10 in European Union and 7 in Japan. There are over 1000 biologics under development which will drive the biologics market in the future. Cancer is the therapeutic area with maximum number of biologics under development and Alzheimers has the least number.
Of the total biologics market across the globe, Monoclonal antibodies (mAbs) accounted for a share of 43% in 2017 and was worth $94 billion. North America had the highest share in 2017 at $39.2 billion followed by Western Europe with a market value of $26.4 billion. Asia-Pacific was the third largest market with a share of 12% and a market value of $11.4 billion. mAbs are biological drugs that recognize and bind to a specific antigen that causes various chronic health conditions such as arthritis, cancer, multiple sclerosis. mAbs can be further segmented based on the presence of different amounts of murine (mouse or rat origin) sequences in the variable region. The segments consist of murine mAbs, chimeric mAbs, human and humanized mAbs. Of these, humanized mAbs accounted for 43% share in the monoclonal antibody market with a market value of $37.6 billion followed by human mAbs and chimeric mAbs at $32.9 billion and $18.8 billion respectively. Murine mAbs accounted only for 5% of the total mAbs market and was worth $4.7 billion in 2017.
Therapeutic proteins or recombinant proteins are engineered in the laboratory and works by targeting therapeutic process which compensates for the deficiency of an essential protein. Therapeutic proteins include cytokines, peptide hormones and enzymes. The market for therapeutic protein was worth $80 billion in 2017 accounting for a share of 36% of the global biologics market. North American market for therapeutic proteins was worth $33 billion in 2017 followed by Western Europe at $17.3 billion. The market in Asia Pacific was worth $11.3 billion and the markets in South America, Eastern Europe, Middle East and Africa accounted only for 4%, 6%, 9% and 4% respectively. Based on the segmentation of therapeutic proteins into cytokines, peptide hormones and enzymes, peptide hormones accounted for 45% of the market followed by cytokines at 18% and enzymes at 10% share. Other blood factors also had a share of around 27% in the total therapeutic proteins market globally.
Vaccines are biological preparations that stimulate the immune system and prepares it to fight future infections caused by pathogens. Vaccines represented around 21% of the global biologics market and was worth $47 billion in 2017. Vaccines are used for prophylactic (preventive) or therapeutic purposes and the market is segmented based on the end users, children and adults. Pediatric vaccines had the major share of 55% and was worth $26 billion globally. Adult vaccines accounted for 45% of the total vaccines market with a value of $21 billion in 2017. North America was the largest market for vaccines in 2017 with a value of $15 billion followed by Asia Pacific at $13 billion. Western and Eastern Europe was valued at $7.1 billion and $3.6 billion respectively. South America and Africa had a share of 7% each and Middle East was observed to account for the least share of 3% in 2017.
The number of biosimilars being approved is on the rise and is likely to affect the overall growth of biologics market globally, by expanding the market, but also by reducing average pricing. Currently, the ratio of biosimilars to biologics sold is quite similar in European Union (EU) and the USA (4% biosimilars and 96% biologics). In Japan and India, the proportion of biosimilars is higher in these markets, almost 13-19%, compared to EU and the USA.
Browse in-depth and report summary TOC on Biologics Market:
https://www.marketinsightsreports.com/reports/0927879758/biologics-global-market-opportunities-and-strategies-to-2021-including-monoclonal-antibodies-therapeutic-proteins-vaccines-covering-amgen-abbvie-johnson-johnson-bristol-meyers-squibb-pfizer-inc-eli-lilly-and-company-f-hoffmann-la-roche-merck-co-glaxosmithkline-sanofi?source=releasewire&Mode=68
What are the market factors that are explained in the report?
Executive Summary: It includes key trends of the global Biologics market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the global Biologics market based on production and revenue.
Production and Consumption by Region: It covers all regional markets focused in the research study. It discusses about prices and key players besides production and consumption in each regional market.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the global Biologics market.
Market Segments: This part of the report discusses about product type and application segments of the global Biologics market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses about the research methodology and approach Biologics used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
Finally, Biologics Market report is the believable source for gaining the Market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request and Market development rate and figure and so on. This report additionally Present new task SWOT examination, speculation attainability investigation, and venture return investigation.
Note: All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.
About MarketInsightsReports
MarketInsightsReports (An Ameliorate Solutions Group Company) provides syndicated market research reports to industries, organizations, or even individuals with the aim of helping them in their decision making process.
These reports include in-depth market research studies i.e. market share analysis, industry analysis, information on products, countries, market size, trends, business research details, and much more.
MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
MarketInsightsReports is your single point market research source for all industries including pharmaceutical, chemicals and materials, energy resources, automobile, IT, technology and media, food and beverages, and consumer goods, among others.
CONTACT US:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com